JP MORGAN/PUT/BOSTON SCIENTIFIC/64/0.1/16.08.24 Stock

Warrant

DE000JK2YW56

Delayed Börse Stuttgart 05:46:51 2024-06-28 EDT
0.043 EUR -4.44% Intraday chart for JP MORGAN/PUT/BOSTON SCIENTIFIC/64/0.1/16.08.24
Current month-48.81%
1 month-33.85%
Date Price Change
24-06-28 0.043 -4.44%
24-06-27 0.045 +21.62%
24-06-26 0.037 -17.78%
24-06-25 0.045 +7.14%
24-06-24 0.042 -12.50%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 05:46 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying BOSTON SCIENTIFIC CORPORATION
Issuer J.P. Morgan
WKN JK2YW5
ISINDE000JK2YW56
Date issued 2024-02-06
Strike 64 $
Maturity 2024-08-16 (47 Days)
Parity 10 : 1
Emission price 0.31
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.55
Lowest since issue 0.037
Delta-0.11x
Omega 11.69
Premium17.82x
Gearing108.41x
Moneyness 0.8311
Difference Strike -13.01 $
Difference Strike %-20.33%
Spread 0.06
Spread %62.50%
Theoretical value 0.0660
Implied Volatility 46.72 %
Total Loss Probability 85.84 %
Intrinsic value 0.000000
Present value 0.0660
Break even 63.29 €
Theta-0.02x
Vega0x
Rho-0x

Company Profile

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Sector
-
More about the company

Ratings for Boston Scientific Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Boston Scientific Corporation

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
77.01 USD
Average target price
82.35 USD
Spread / Average Target
+6.94%
Consensus